<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00501956</url>
  </required_header>
  <id_info>
    <org_study_id>IDPN 24332</org_study_id>
    <nct_id>NCT00501956</nct_id>
  </id_info>
  <brief_title>Intradialytic Parenteral Nutrition in Hemodialysis Patients</brief_title>
  <acronym>IDPNHD</acronym>
  <official_title>Randomized Study on the Effect of Intradialytic Parenteral Nutrition in Malnourished Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fresenius Kabi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is a major cause of death in chronic hemodialysis patients. Primary treatment of
      malnutrition in these patients is dietetic counseling, additional enteral nutrition and
      occasionally drug therapy.

      In cases where primary treatment of malnutrition is not effective, intradialytic parenteral
      nutrition (IDPN)during dialysis therapy may be administered. Using IDPN aminoacids,
      carbohydrates and fatty acids as well as vitamins and trace elements can be given to the
      patients.

      Effectiveness of IDPN has to be verified.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      25% of hemodialysis patients who are treated for more than 5 years suffer from protein
      malnutrition. 7% have a protein catabolic rate less than 0,6 g/kgBW and day.

      The conventional treatment of malnutrition include dietetic counseling, psychologic advice
      and giving additional oral nutrients.In many cases this kind of therapy is uneffective. If
      supplementary enteral nutrition is used, the additional intake of water has to be taken into
      consideration.

      IDPN is a mode of treatment by which disadvantages of enteral nutrition and fluid overload of
      the patients can be avoided.During each dialysis session nutrients can be given and
      additional water simultaneously can be removed by ultrafiltration.

      Some publications have shown that the catabolic state of the patients can be converted into
      an anabolic state. There are only small randomized studies showing the positive effect of
      IDPN.

      In this german multicenter study malnourished hemodialysis patients are randomized into two
      groups. One group is treated with IDPN during each dialysis session for 16 weeks followed by
      12 weeks of follow-up without IDPN. The control-group does not receive IDPN.

      The parameters of metabolism are: Albumin, prealbumin, transferrin, phase angle alpha
      (bioimpedance), proteincatabolic rate (formal urea kinetics), BMI and subjective global
      assessment (SGA score).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in prealbumin levels</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum albumin, transferrin, nutritional status</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Malnutrition</condition>
  <condition>Complication of Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Intradialytic parenteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individually compounded intradialytic parenteral nutrition (IDPN) including glucose, amino acids, lipids, L-Carnitine, trace elements and water-soluable vitamins 3x / week over 16 weeks + 12 weeks postinterventional observation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Observation over 28 weeks (16 + 12 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intradialytic Parenteral Nutrition (IDPN)</intervention_name>
    <description>compounded IDPN, 3 x/week, 16 weeks intervention</description>
    <arm_group_label>Intradialytic parenteral nutrition</arm_group_label>
    <other_name>Individually compounded parenteral nutrition</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemodialysis therapy more than 6 months

          -  three times per week hemodialysis

          -  albumin &lt; 35 g/l

          -  prealbumin &lt; 250 mg/l

          -  phase angle &lt; 4,5Â°

          -  SGA score grade B or C

          -  informed consent

        Exclusion Criteria:

          -  inadequate dialysis (Kt/V &lt; 1,2)

          -  chemotherapy or radiotherapy

          -  cardiac pacemaker

          -  acute bacterial infection

          -  acute immunological disease

          -  cancer disease

          -  severe hepatic insufficiency

          -  interferon therapy

          -  HIV disease

          -  severe diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Mann, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interneph e.V, Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Interneph e.V. Institute for Applied Nephrology</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002 Aug;110(4):437-9.</citation>
    <PMID>12189236</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2007</study_first_submitted>
  <study_first_submitted_qc>July 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2007</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic renal replacement therapy</keyword>
  <keyword>malnutrition anorexia</keyword>
  <keyword>parenteral nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

